Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

Abstract Introduction Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if w...

Full description

Bibliographic Details
Main Authors: Hellen Musana, Jude Thaddeus Ssensamba, Mary Nakafeero, Henry Mugerwa, Flavia Matovu Kiweewa, David Serwadda, Francis Ssali
Format: Article
Language:English
Published: BMC 2021-04-01
Series:AIDS Research and Therapy
Subjects:
Second-line ART failure
Predictors
Protease inhibitor mutations
Uganda
Online Access:https://doi.org/10.1186/s12981-021-00338-y

Internet

https://doi.org/10.1186/s12981-021-00338-y

Similar Items